Steadvar — News without the noise

Privacy · Terms · About

© 2026 Steadvar. All rights reserved.

Colossal Biosciences Aims to Revive Extinct Bluebuck Antelope by 2028

ScienceEnvironment4/30/2026
Share

Similar Articles

New Species of Ancient Mammal Discovered in Baja California Fossil

Science4/27/2026

Genetic Rescue Program Aims to Revive Extinct-in-the-Wild Australian Bandicoot

EnvironmentScience4/26/2026

Colombia Plans to Cull Escobar's Hippos as Population Control Measure

EnvironmentWorld3d ago

Four Critically Endangered Mountain Bongos Return to Kenya from European Conservation Program

EnvironmentWorld2d ago

New Mining Company Seeks to Prospect for Critical Minerals in South Africa's Northern Cape

BusinessEnvironment4/23/2026

Colossal Biosciences has added the extinct bluebuck antelope to its de-extinction portfolio, aiming for a birth around 2028. The company is in the final phase of genomic editing for the project and has support from South African conservation groups. Its flagship woolly mammoth revival effort remains on track for a similar timeline.

Facts First

  • Colossal Biosciences aims to revive the extinct bluebuck antelope, a species that disappeared over 200 years ago.
  • The bluebuck project is in the final phase of genomic editing, with a birth targeted for '2028-ish' via a surrogate.
  • The company's woolly mammoth project is also on track for a first birth in 2028, with editing in its last stages.
  • Colossal's de-extinction work is supported by conservation groups and involves partnerships with governments and scientists.
  • The company has no plans for a traditional zoo, though revived species could live in public ecological preserves.

What Happened

Colossal Biosciences announced it is working to revive the bluebuck, an antelope species that went extinct in modern-day South Africa more than two centuries ago. This is the sixth species in the company's de-extinction portfolio. The company has obtained, mapped, and compared bluebuck DNA to its closest living relatives and the project is currently in the final phase of genomic editing. CEO Ben Lamm stated the company is aiming for a bluebuck birth in '2028-ish' following a nine-month gestation period via a surrogate.

Why this Matters to You

De-extinction science may one day allow you to see species lost for centuries, potentially in ecological preserves open to the public. This work could contribute to broader conservation and ecological restoration efforts, though the direct, tangible impacts on daily life are not yet clear.

What's Next

The next major step for the bluebuck project is the embryo transfer into a surrogate, which could lead to a birth around 2028. Colossal Biosciences' woolly mammoth team is also in the last stages of editing, with the next stage involving embryo transfer into elephants. The company's partnerships with governments, scientists, and indigenous peoples will likely be crucial for the eventual rewilding of any revived species.

Perspectives

“
Company Leadership maintains that de-extinction efforts will foster technological innovation, support biodiversity, and provide animals with habitats where they can become 'accretive to the ecosystem.'
“
Skeptics question the scientific authenticity of the company's output and suggest that the work may not be as significant as claimed.
“
Environmental Critics argue that de-extinction efforts pose potential ecological risks and contend that reviving extinct species is 'an awful idea.'